select trial semaglutide results , AND CVS OUTCOMES IN OBESITY WITHOUT DIABETES SELECT Cardiovascular Trial Information |
Description
Semaglutide and similar GLP-1 medications are increasingly prescribed for prediabetes management, not just type 2 diabetes

A new study published in the European Heart Journal showed that semaglutide is a helpful additional medication for the individuals who are obese and have high blood pressure.Even with the...

The World Health Organisation's 2026 global guidelines on GLP-1 therapies for obesity explicitly recommend combining medication with intensive behavioural interventions, including structured goal-setting for diet and physical activity

Clinical studies show results as early as 4 weeks

We're treating these medications as standalone solutions rather than tools within a comprehensive metabolic health program

Learn more about the CoolSculpting results most patients experience, how long fat-reduction lasts, and find out what you can do to get good results.
